Citalopram-induced photopigmentation.
Citalopram is one of the newer and most potent selective serotonin re-uptake inhibitor (SSRI) drugs. It has a well-established antidepressive action with a favorable adverse event profile. We present a fifty-year-old woman with diffuse photopigmentation who had been diagnosed as suffering from depression. The patient was given citalopram (40 mg/day) for her psychiatric condition and diffuse photopigmentation was noted thereafter. To our knowledge, such an adverse event has not been reported previously.
Inalöz
H S
HS
Department of Dermatology, University of Gaziantep Faculty of Medicine, Turkey.
Kirtak
N
N
Herken
H
H
Ozgöztaşi
O
O
Aynacioğlu
A S
AS
D015283:Citalopram / Q000009:adverse effects*; D003863:Depression / Q000188:drug therapy; D003937:Diagnosis, Differential; D005145:Face; D005260:Female; D005542:Forearm; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced / Q000175:diagnosis*; D008875:Middle Aged; D009333:Neck; D010787:Photosensitivity Disorders / Q000139:chemically induced / Q000175:diagnosis*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors